CLINICAL STUDY TO EVALUATE THE THERAPEUTIC EFFECT OF BALAGUDUCYADI BASTI AND BALUKA SWEDAN IN THE CASE OF AMAVATA (RHEUMATOID ARTHRITIS)
DOI:
https://doi.org/10.70066/jahm.v5i1.40Keywords:
Amvata, Rheumatoid Arthritis, Basti Therapy, balaguducyadi basti, baluka swedanaAbstract
Background: Amavata is the commonest disorder seen in middle age people which affects both sex characterized by Angamarda (Body pain), Aruchi (loss of taste), Trishna (Thirst), Alasya (Lack of enthusiasm), Gaurava (Heaviness), Klama (Tiredness without doing work), Apaka (Indigestion) and fever. In later stage pain may begin to migrate from place to place with a Vriskchikadamshovata vedana (Intense pain). The disease “Amavata” can be co-related with Rheumatoid Arthitis. It is an autoimmune disease that cause chronic inflammation of joints mainly peripheral joints associated with varied constitutional symptoms and presence of Rheumatoid factor. Objective: To evaluate the therapeutic effect of balaguducyadi basti and baluka swedana in the case of Amavata. Material and methods: In the present clinical study 30 patients suffering with Amvata were selected randomly from OPD of Sree Baba Mastnath Ayurved College, Rohtak and divided into 2 groups with 15 patients each, administered with Valuka swedana followed by BalaguducyadiBasti for a period of 23 days. The result of this study was found encouraging. By comparison Group B (BalukaSwedana followed by Basti therapy) showed a better result than Balukaswedan (Group A) only. Conclusion: Amvata can be efficiently and effectively managed with this said therapy and the complication can be prevented.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 BERA PABITRA KUMAR

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.